News

A novel cutting-edge technology is accelerating the development of next-generation cancer treatments, with AIBN now home to an AdvanCell Lead-212 generator.

Queensland is cementing its global leadership in mRNA science with the launch of a new protocol designed to make its research more accessible than ever before.

A revolutionary wound care technology developed at AIBN is a step closer to market, with the potential to save lives and transform trauma care across outback Queensland.

University of Queensland PhD student Hemanshi Galaiya has been named a 2025 Universitas 21 Leader of the Future, recognised for her work expanding access to STEM education for under-resourced students in Kenya.

Proud Gubbi Gubbi man Dr Francis McCallum from The University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) has been awarded a prestigious fellowship to advance microchip research in Japan.

A breakthrough in sustainable solar energy is moving closer to market, thanks to a new partnership between The University of Queensland (UQ) and clean technology company Halocell Energy.

Construction is underway on The University of Queensland’s new $60-million Biosustainability Hub, a state-of-the-art facility designed to accelerate the transition to a sustainable global bioeconomy.  

Researchers from the AIBN will play a key collaborative role in a national effort to revolutionise treatment options for patients with prostate cancer.

Researchers from the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology are calling for global benchmarking to fast-track PFAS research and remediation efforts.

Researchers at The University of Queensland have set a new world record efficiency for lead-free perovskite solar cells, advancing the development of safer, more sustainable solar technologies.

Researchers at the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology are working to develop a vaccine in just 100 days to support future pandemic preparedness.

AIBN Emerging Group Leader Dr Run Zhang has secured a grant from the Food and Beverage Accelerator (FaBA) to advance sensor technology that detects antibiotic residues in food, improving food safety.

University of Queensland researchers are taking up the fight against one of the deadliest forms of breast cancer, developing next-generation nanoparticles to supercharge current treatments for triple-negative breast cancer.

The long-standing partnership between AIBN and Clarity Pharmaceuticals continues to thrive with the signing of a brand-new Supply Agreement for radionuclide, Copper-64.

New international research has its sights set on mosquito-borne neurotropic viruses, like dengue and Japanese Encephalitis, which are a growing global threat, with limited treatment options.

In the wake of the COVID-19 pandemic, new viral threats are considered an inevitability – particularly as our climate changes and, with it, human behaviour and demographics. For Emmanuel Hanon this means we need new ways to keep people healthy, and fast.

A newly discovered genomic immunity to an AIDs like retrovirus plaguing Australia’s koala population offers hope in the effort to save the beloved but endangered marsupial.

An update from the AIBN Director: Highlights from BioAsia 2025

University of Queensland researchers have developed an advanced sensor that can detect pregnancy complications as early as 11 weeks with a simple blood test – well before traditional screening methods.

AIBN researchers have turned to the most abundant organic compound on earth to help them transform a common weedkiller into a nano-herbicide that boosts plant hydration.